Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about AMYLOID-Β: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | AMYLOID-Β |
| Key Genes/Proteins | APP, CLU, PSEN1 |
| Related Diseases | Alzheimer Disease, Alzheimer's disease, Alzheimer's Disease, neurodegenerative diseases |
graph TD
AMYLOID__["AMYLOID-Beta"]
AMYLOID__ -->|"contributes to"| ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"]
AMYLOID__ -.biomarker for.-> Alzheimer_S_Disease["Alzheimer'S Disease"]
AMYLOID__ -->|"causes"| Neurofibrillary_Tangles["Neurofibrillary Tangles"]
AMYLOID__ -->|"modulates"| Astrocytes["Astrocytes"]
AMYLOID__ -->|"involved_in"| Intracellular_Aggregation["Intracellular Aggregation"]
LRP1["LRP1"] -->|"regulates"| AMYLOID__
LRP1_targeted_Polymersomes["LRP1-targeted Polymersomes"] -->|"targets"| AMYLOID__
Modified_Antibody["Modified Antibody"] -->|"targets"| AMYLOID__| Target | Relation | Type | Str |
|---|---|---|---|
| Alzheimer'S Disease | associated_with | disease | 0.95 |
| ALZHEIMER'S DISEASE | contributes_to | entity | 0.95 |
| Alzheimer'S Disease | biomarker_for | disease | 0.95 |
| Inflammation | associated_with | process | 0.95 |
| alzheimer_disease | biomarker_for | disease | 0.95 |
| Alzheimer Disease | associated_with | disease | 0.95 |
| Alzheimer's Disease | biomarker_for | disease | 0.95 |
| Neurofibrillary Tangles | causes | biomarker | 0.95 |
| Alzheimer Disease | biomarker_for | disease | 0.95 |
| Alzheimer's Disease | involved_in | disease | 0.95 |
| ALZHEIMER | causes | disease | 0.95 |
| PANoptosis | activates | process | 0.92 |
| Alzheimer's Disease | causes | disease | 0.90 |
| Microglia | activates | cell_type | 0.90 |
| Alzheimer's Disease | involved_in | disease | 0.90 |
| Alzheimer's disease | biomarker_for | disease | 0.90 |
| Astrocytes | modulates | cell_type | 0.90 |
| Amyloid Plaques | associated_with | entity | 0.90 |
| Alzheimer's disease | associated_with | disease | 0.90 |
| ALZHEIMER'S DISEASE | biomarker_for | disease | 0.90 |
| Post-Stroke Cognitive Impairment | involved_in | disease | 0.89 |
| Tau Phosphorylation | associated_with | process | 0.85 |
| tau | promotes | protein | 0.85 |
| cognitive decline | drives | phenotype | 0.85 |
| Microglia | activates | cell_type | 0.85 |
| Alzheimer'S Disease | causes | disease | 0.85 |
| synaptopathy | causes | process | 0.85 |
| Proteostasis dysfunction | contributes_to | process | 0.85 |
| Intracellular Aggregation | involved_in | process | 0.85 |
| plasma biomarkers | biomarker_for | process | 0.85 |
| pathological seeds | associated_with | protein | 0.85 |
| Mitochondrial Stress | causes | process | 0.85 |
| MICROGLIA | activates | cell_type | 0.80 |
| neurodegenerative diseases | implicated_in | disease | 0.80 |
| Alzheimer's disease | implicated_in | disease | 0.80 |
| Alzheimer's disease | causes | disease | 0.80 |
| synaptic dysfunction | causes | process | 0.80 |
| synapse loss | causes | process | 0.80 |
| Alzheimer's Disease | causes | disease | 0.80 |
| amyloid-related imaging abnormalities | causes | phenotype | 0.80 |
| microglial_activation | activates | mechanism | 0.80 |
| Alzheimer's disease | causes | disease | 0.70 |
| protein aggregates | causes | process | 0.70 |
| Alzheimer's disease | causes | disease | 0.70 |
| apoptosis | activates | process | 0.70 |
| Alzheimer's disease | associated_with | disease | 0.70 |
| mitophagy | inhibits | process | 0.70 |
| Tau | mediates | protein | 0.70 |
| Tau | associated_with | protein | 0.70 |
| lipid droplet formation | activates | process | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Donanemab | targets | drug | 0.95 |
| donanemab | binds_to | drug | 0.95 |
| Lecanemab | targets | drug | 0.95 |
| BACE1 | associated_with | entity | 0.95 |
| LRP1-targeted Polymersomes | targets | drug | 0.95 |
| Donanemab | targets | drug | 0.95 |
| Lecanemab | targets | drug | 0.95 |
| Modified Antibody | targets | drug | 0.95 |
| LRP1 | regulates | entity | 0.95 |
| Modified Antibody | targets | drug | 0.95 |
| APP | produces | gene | 0.95 |
| Γ-SECRETASE | produces | enzyme | 0.95 |
| APP | associated_with | protein | 0.95 |
| APP | associated_with | gene | 0.95 |
| Lecanemab | targets | drug | 0.92 |
| Donanemab | targets | drug | 0.92 |
| APOE | associated_with | gene | 0.90 |
| Ceramide | contributes_to | compound | 0.90 |
| APOE ε2 | inhibits | gene | 0.90 |
| TAU | interacts_with | protein | 0.90 |
| APOE | interacts_with | gene | 0.90 |
| Amyloid Precursor Protein | associated_with | protein | 0.90 |
| Presenilin Complex | associated_with | entity | 0.90 |
| MTOR | promotes | gene | 0.90 |
| apoE | interacts_with | protein | 0.90 |
| PSEN1 | associated_with | protein | 0.90 |
| aducanumab | targets | drug | 0.90 |
| PSEN1 | upregulates | gene | 0.90 |
| CLU | interacts_with | protein | 0.90 |
| PSEN1 | upregulates | gene | 0.85 |
| PSEN2 | upregulates | gene | 0.85 |
| Mtor Inhibition | associated_with | mechanism | 0.85 |
| TFEB | promotes | protein | 0.85 |
| Hdac3 Inhibition | associated_with | mechanism | 0.85 |
| Aducanumab | targets | drug | 0.85 |
| Lysosomal Degradation | degrades | process | 0.85 |
| GLP-1R | prevents | protein | 0.85 |
| APOE | associated_with | protein | 0.85 |
| amyloid hypothesis | associated_with | pathway | 0.85 |
| CYP46A1 | regulates | gene | 0.80 |
| Alzheimer's Disease | causes | disease | 0.80 |
| ABCA7 | transports | gene | 0.80 |
| CROCETIN | promotes clearance of | compound | 0.80 |
| HMGCR | regulates | gene | 0.80 |
| VDAC1 | interacts_with | gene | 0.80 |
| NBR1 | regulates | protein | 0.70 |
| BECN1 | regulates | protein | 0.70 |
| depression | associated_with | disease | 0.70 |
| autophagy | protects_against | process | 0.70 |
| autophagy | regulates | process | 0.70 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning AMYLOID-Β in their description or question text
No additional research found